FDA Clearance Tracker · K230926
Ova+ (K-OVAP-USA)
Last checked: Nov 20, 2026Latest source record: Dec 15, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Dec 15, 2023
Substantially Equivalent
Time to decision
256 days
Received Apr 3, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K230926
- Device name
- Ova+ (K-OVAP-USA)
- Applicant
- Tenscare, Ltd.
- Applicant location
- Epsom, GB
- Received
- Apr 3, 2023
- Decided
- Dec 15, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.5890
- Specialty
- Neurology & Neurosurgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NUH. The earliest in FDA's data is K033122, decided Aug 25, 2004.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K230926
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Tenscare, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Unipro (K-UNIPRO-US)510(k)
K232441 · Decided Aug 30, 2024 · 382 days after receipt
Device type: Stimulator, Nerve, Transcutaneous, For Pain Relief (GZJ) · Neurology & Neurosurgery
- Unicare (K-UNICARE-USA)510(k)
K230983 · Decided Oct 20, 2023 · 197 days after receipt
Device type: Stimulator, Electrical, Non-Implantable, For Incontinence (KPI) · GI, Urology & Nephrology
- Unicare (K-UNICARE-USA)510(k)
K231053 · Decided Aug 18, 2023 · 127 days after receipt
Device type: Stimulator, Nerve, Transcutaneous, Over-The-Counter (NUH) · Neurology & Neurosurgery
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.